Small particle-size talc is associated with poor outcome and increased inflammation in thoracoscopic pleurodesis

Respiration

Volumn 86, Issue 3, 2013, Pages 201-209

  Arellano Orden, Elena ^a   Romero Falcon, Auxiliadora ^a   Juan, José Martin ^a   Ocaña Jurado, Manuel ^a   Rodriguez Panadero, Francisco ^a,b   Montes Worboys, Ana ^a,b  

^a HOSPITAL UNIVERSITARIO VIRGEN DEL ROCÍO   (Spain)

^b INSTITUTO DE SALUD CARLOS III   (Spain)

Author keywords

Inflammation; Malignant effusion; Pleural effusion; Pleurodesis; Talc; Thoracoscopy

Indexed keywords

BIOLOGICAL MARKER; FIBROBLAST GROWTH FACTOR 2; INTERLEUKIN 8; STERITALC; TALC; THROMBIN ANTITHROMBIN COMPLEX; TUMOR NECROSIS FACTOR ALPHA; UNCLASSIFIED DRUG; VASCULOTROPIN;

ADULT; ARTICLE; BLOOD SAMPLING; CONTROLLED STUDY; CYTOKINE PRODUCTION; DEATH; DISEASE ASSOCIATION; DRUG SAFETY; DYSPNEA; EX VIVO STUDY; FEMALE; HUMAN; HYPOTHESIS; IN VITRO STUDY; MAJOR CLINICAL STUDY; MALE; MESOTHELIUM CELL; PAIN; PARTICLE SIZE; PLEURA CAVITY; PLEURA EFFUSION; PLEURA FLUID; PLEURA TUMOR; PLEURISY; PLEURODESIS; PRIORITY JOURNAL; SCANNING ELECTRON MICROSCOPY; SUPERNATANT; SYSTEMIC CIRCULATION; THORACOSCOPY; THROMBOSIS; TUMOR VOLUME; ADULT RESPIRATORY DISTRESS SYNDROME; HUMAN CELL; INFLAMMATION; MALIGNANT PLEURA EFFUSION; MIDDLE AGED; TREATMENT OUTCOME;

BIOLOGICAL MARKERS; BLOOD COAGULATION FACTORS; CELLS, CULTURED; CYTOKINES; FEMALE; HUMANS; INTERCELLULAR SIGNALING PEPTIDES AND PROTEINS; LUNG DISEASES; MALE; MIDDLE AGED; PARTICLE SIZE; PLEURAL EFFUSION, MALIGNANT; PLEURAL NEOPLASMS; PLEURODESIS; RETROSPECTIVE STUDIES; SPAIN; TALC; THORACOSCOPY; TUMOR BURDEN;

EID: 84885078274     PISSN: 00257931     EISSN: 14230356     Source Type: Journal    
DOI: 10.1159/000342042     Document Type: Article

References (22)

1. Rinaldo JE, Owens GR, Rogers RM: Adult respiratory distress syndrome following intrapleural instillation of talc. J Thorac Cardiovasc Surg 1983; 85: 523-526.
2. Bouchama A, Chastre J, Gaudichet A, Soler P, Gilbert C: Acute pneumonitis with bilateral pleural effusion after talc pleurodesis. Chest 1984; 86: 795-797.
3. Kennedy L, Rusch VW, Strange C, Ginsberg RJ, Sahn SA: Pleurodesis using talc slurry. Chest 1994; 106: 342-346.
4. Rehse HD, Aye WR, Florence GM: Respiratory failure following talc pleurodesis. Am J Surg 1999; 177: 437-440.
5. Campos JR, Werebe EC, Vargas FS, Jatene FB, Light RW: Respiratory failure due to insufflated talc. Lancet 1997; 349: 251-252.
6. Ferrer J, Montes JF, Villarino MA, Light RW, García-Valero J: Influence of particle size on extrapleural talc dissemination after talc slurry pleurodesis. Chest 2002; 122: 1018-1027.
7. Maskell NA, Lee YC, Gleeson FV, Hedley EL, Pengelly G, Davies RJO: Randomized trials describing lung inflammation after pleurodesis with talc of varying particle size. Am J Respir Crit Care Med 2004; 170: 377-382.
8. Werebe EC, Pazetti R, Milanez de Campos JR, Fernandez PP, Capelozzi VL, Jatene FB, Vargas FS: Systemic distribution of talc after intrapleural administration in rats. Chest 1999; 115: 190-193.
9. Fraticelli A, Robaglia-Schlupp A, Riera H, Monjanel-Mouterde S, Cau P, Astoul P: Distribution of calibrated talc after intrapleural administration: an experimental study in rats. Chest 2002; 122: 1737-1741.
10. Janssen JP, Collier G, Astoul P, Tassi GF, Noppen M, Rodriguez-Panadero F, et al: Safety of pleurodesis with talc poudrage in malignant pleural effusion: a prospective cohort study. Lancet 2007; 369: 1535-1539.
11. Gill AJ, Mathur MN, Tattersall SF: Systematic response to talc pleurodesis. Am J Respir Crit Care Med 2004; 169: 1074-1075.
12. Genofre EH, Vargas FS, Acencio M, Antonangelo L, Texeira LR, Marchi E: Talc pleurodesis: evidence of systemic inflammatory response to small size talc particles. Respir Med 2009; 103: 91-97.
13. Rossi VF, Vargas FS, Marchi E, Acencio MM, Genofre EH, Capelozzi VL, Antonangelo L: Acute inflammatory response secondary to intrapleural administration of two types of talc. Eur Respir J 2010; 35: 396-401.
14. Rodriguez Panadero F: Medical thoracoscopy. Respiration 2008; 76: 363-372.
15. Sanchez-Armengol A, Rodriguez-Panadero F: Survival and talc pleurodesis in metastatic pleural carcinoma, revisited. Report of 125 cases. Chest 1993; 104: 1482-1485.
16. Antony VB, Loddenkemper R, Astoul P, Boutin C, Goldstraw P, Hott J, Rodriguez Panadero F, Sahn SA: Management of malignant pleural effusions. Eur Respir J 2001; 18: 402-419.
17. Nasreen N, Mohammed KA, Dowling PA, Ward MJ, Galffy G, Antony VB: Talc induces apoptosis in human malignant mesothelioma cells in vitro. Am J Respir Crit Care Med 2000; 161: 595-600.
18. Miller Q, Meschter C, Neumaster T, Pratt J, Moulton M, Downey D, Harre J: Comparison of pleurodesis by erythromycin, talc, doxycycline, and diazepam in a rabbit model. J Surg Educ 2007; 64: 41-45.
19. Froudarakis ME, Klimathianaki M, Pougounias M: Systemic inflammatory reaction after thoracoscopic talc poudrage. Chest 2006; 129: 356-361.
20. Psathakis K, Calderon-Osuna E, Romero-Romero B, et al: The neutrophilic and fibrinolytic response to talc can predict the outcome of pleurodesis. Eur Respir J 2006; 27: 817-821.
21. Rodriguez-Panadero F, Montes-Worboys A: Mechanisms of pleurodesis. Respiration 2012; 83: 91-98.
22. Montes-Worboys A, Rodriguez-Portal JA, Arellano-Orden E, Digón-Pereiras J, Rodriguez-Panadero F: Interleukin-8 activates coagulation and correlates with survival after talc pleurodesis. Eur Respir J 2010; 35: 160-166.